Changes in rheumatoid arthritis medication in pregnancy: a retrospective observational study using a Japanese claims database
Modern Rheumatology · 2025
DOI: 10.1093/mr/roaf106 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Modern Rheumatology, 2025. Verfasst von Yuichi Shiotsuki und 4 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Health Management, Keio University, Fujisawa-shi, Japan. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Antirheumatic Agents, Pregnancy Complications. Die Arbeit nennt 25 Literaturangaben. Gefördert von: Health Labour Sciences Research Grant.
Abstract (Originalsprache)
Objectives
To examine changes in rheumatoid arthritis (RA) medication prescriptions during the peri-delivery period, and to explore recent RA prescription trends using a Japanese claims database.
Methods
This retrospective observational cohort study used an insurance claims database provided by JMDC Inc. We identified pregnant women with RA who delivered between April 2018 and October 2023. The outcome was the initiation or resumption of intensive treatment after delivery, defined as new or restarting of biologic disease modifying anti-rheumatic drugs (DMARDs), targeted synthetic DMARDs, oral corticosteroids (OCS), or methotrexate.
Results
We identified 229 mothers with RA and 246 deliveries. Intensive treatment was initiated in 55 (22.4%) deliveries. Continuation of the same prescription from before delivery was observed in 106 (43.1%) deliveries. The most frequent new prescription postpartum was methotrexate in 18 (7.3%) deliveries. OCS were the most commonly prescribed medications throughout the observation period. Tumour necrosis factor alpha inhibitors were prescribed at similar rates as OCS before pregnancy and in the first trimester, but declined during the second and third trimesters, and returned postpartum.
Conclusions
The number of deliveries that required intensive treatment postpartum was lower than in previous studies. Our results suggest that the latest guidelines for pregnant women with RA help control disease activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate School of Health Management, Keio University, Fujisawa-shi, Japan.
- Real World Evidence Division, Pharmaceutical Business Unit, JMDC Inc., Tokyo, Japan.
- Department of Preventive Medicine and Public Health, Keio University School of Medicine, Tokyo, Japan.
- Faculty of Nursing and Medical Care, Keio University, Fujisawa-shi, Japan.
ORCID-Profile: Yuichi Shiotsuki, Miho Iida, Shiori Tsuchiya, Minako Matsumoto, Daisuke Sugiyama
Förderung
- Health Labour Sciences Research Grant
Zitieren
APA
Shiotsuki, Y., Iida, M., Tsuchiya, S., Matsumoto, M., & Sugiyama, D. (2025). Changes in rheumatoid arthritis medication in pregnancy: a retrospective observational study using a Japanese claims database. Modern Rheumatology. https://doi.org/10.1093/mr/roaf106
Vancouver
Shiotsuki Y, Iida M, Tsuchiya S, Matsumoto M, Sugiyama D. Changes in rheumatoid arthritis medication in pregnancy: a retrospective observational study using a Japanese claims database. Modern Rheumatology. 2025. doi:10.1093/mr/roaf106
BibTeX
@article{Shiotsuki2025,
author = {Shiotsuki, Yuichi and Iida, Miho and Tsuchiya, Shiori and Matsumoto, Minako and Sugiyama, Daisuke},
title = {Changes in rheumatoid arthritis medication in pregnancy: a retrospective observational study using a Japanese claims database},
journal = {Modern Rheumatology},
year = {2025},
doi = {10.1093/mr/roaf106}
}
EUVIMED